Trial Profile
A Phase 1, Two-Part, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BMN 111 Administered to Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2014
Price :
$35
*
At a glance
- Drugs Vosoritide (Primary)
- Indications Achondroplasia
- Focus Adverse reactions
- Sponsors BioMarin Pharmaceutical
- 04 Dec 2014 New trial record